Researchers have uncovered how proteins normally active only before birth can drive aggressive lung cancer, opening new ...
Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...
Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...
CLEVELAND, Ohio — A drug developed decades ago by an Ohio University professor shows new potential to make treatment-resistant lung cancer cells more sensitive to chemotherapy. The drug blocks growth ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...
Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis and removal using two different robotic systems at Roper could change that ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...
On Wednesday, March 25, Enosburg resident and lung cancer survivor, George Flower, will travel to Washington, D.C., for the American Lung Association’s 11th annual LUNG FORCE Advocacy Day. He will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results